Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C F Bennett

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
Antisense & Nucleic Acid Drug Development|May 4, 2001
ADAM17 but not ADAM10 mediates tumor necrosis factor-alpha and L-selectin shedding from leukocyte membranesT P Condon, S Flournoy, G J Sawyer, et al.
Transplantation Proceedings|December 26, 2001
An oral formulation for intracellular adhesion molecules-1 antisense oligonucleotidesS M Stepkowski, W Chen, R Geary, et al.
Antisense & Nucleic Acid Drug Development|November 15, 1997
Characterization and modulation of immune stimulation by modified oligonucleotidesR T Boggs, K McGraw, T Condon, et al.
Cancer Letters|July 4, 1998
Human melanoma metastasis is inhibited following ex vivo treatment with an antisense oligonucleotide to protein kinase C-alphaJ U Dennis, N M Dean, C F Bennett, et al.
Journal of Pharmaceutical Sciences|April 1, 1994
Lipid membrane permeability of 2'-modified derivatives of phosphorothioate oligonucleotidesJ A Hughes, C F Bennett, P D Cook, et al.
Transplantation Proceedings|December 26, 2001
Phosphorothioate/methoxyethyl-modified ICAM-1 antisense oligonucleotides improves prevention of ischemic/reperfusion injuryS M Stepkowski, W Chen, C F Bennett, et al.
Transplantation Proceedings|March 27, 2001
Methoxyethyl modification of phosphorothioate ICAM-1 antisense oligonucleotides improves prevention of ischemic/reperfusion injuryW Chen, C F Bennett, T P Condon, et al.
Trends in Pharmacological Sciences|March 1, 1989
The signal transduction system of the leukotriene D4 receptorS T Crooke, M Mattern, H M Sarau, et al.
Anti-Cancer Drug Design|February 1, 1993
Growth inhibition of human tumor cell lines by antisense oligonucleotides designed to inhibit p120 expressionL Perlaky, Y Saijo, R K Busch, et al.
The Journal of Biological Chemistry|March 30, 2001
A constitutive cytoprotective pathway protects endothelial cells from lipopolysaccharide-induced apoptosisD D Bannerman, J C Tupper, W A Ricketts, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
Antisense & Nucleic Acid Drug Development|May 4, 2001
ADAM17 but not ADAM10 mediates tumor necrosis factor-alpha and L-selectin shedding from leukocyte membranesT P Condon, S Flournoy, G J Sawyer, et al.
Transplantation Proceedings|December 26, 2001
An oral formulation for intracellular adhesion molecules-1 antisense oligonucleotidesS M Stepkowski, W Chen, R Geary, et al.
Antisense & Nucleic Acid Drug Development|November 15, 1997
Characterization and modulation of immune stimulation by modified oligonucleotidesR T Boggs, K McGraw, T Condon, et al.
Cancer Letters|July 4, 1998
Human melanoma metastasis is inhibited following ex vivo treatment with an antisense oligonucleotide to protein kinase C-alphaJ U Dennis, N M Dean, C F Bennett, et al.
Journal of Pharmaceutical Sciences|April 1, 1994
Lipid membrane permeability of 2'-modified derivatives of phosphorothioate oligonucleotidesJ A Hughes, C F Bennett, P D Cook, et al.
Transplantation Proceedings|December 26, 2001
Phosphorothioate/methoxyethyl-modified ICAM-1 antisense oligonucleotides improves prevention of ischemic/reperfusion injuryS M Stepkowski, W Chen, C F Bennett, et al.
Transplantation Proceedings|March 27, 2001
Methoxyethyl modification of phosphorothioate ICAM-1 antisense oligonucleotides improves prevention of ischemic/reperfusion injuryW Chen, C F Bennett, T P Condon, et al.
Trends in Pharmacological Sciences|March 1, 1989
The signal transduction system of the leukotriene D4 receptorS T Crooke, M Mattern, H M Sarau, et al.
Anti-Cancer Drug Design|February 1, 1993
Growth inhibition of human tumor cell lines by antisense oligonucleotides designed to inhibit p120 expressionL Perlaky, Y Saijo, R K Busch, et al.
The Journal of Biological Chemistry|March 30, 2001
A constitutive cytoprotective pathway protects endothelial cells from lipopolysaccharide-induced apoptosisD D Bannerman, J C Tupper, W A Ricketts, et al.
Pageof 10